Xeris Biopharma Holdings Inc is a Chicago-based biopharmaceutical firm focused on creating and bringing to market treatments for various medical conditions. Its flagship products include Gvoke, a ready-to-use glucagon for severe hypoglycemia; Keveyis, for primary periodic paralysis; and Recorlev, aimed at treating Cushing’s syndrome. Beyond these, Xeris is working on expanding its product range and applications through innovative technologies like XeriSol and XeriJect. Founded in 2005, the company is dedicated to addressing unmet medical needs.
Are you interested in investing in penny stocks? Though doing so does come with risk, making the right investment decisions in the penny stock category can produce eye-opening returns. While the profits…
